This study analyzed eucalyptus residue and found 55 compounds, including triterpenoids with antitumor activity. Triterpenoids could be enhanced to 82% and showed inhibitory effects on breast, gastric, and cervical cancer cells. Potential for development as antitumor drugs.
Traditional medicinal plants in Thailand, (DLEE), (FREE), and (HPEE), were evaluated for their anti-cancer properties against A549 lung adenocarcinoma cells. Only DLEE showed cytotoxic effects, inhibiting cell proliferation and inducing apoptosis. This suggests that DLEE may have potential as a treatment for NSCLC.
An optimized extract of L demonstrated comparable anti-inflammatory properties to a control group and reduced tumor-associated inflammation and oxidative stress, suggesting its potential as a natural therapeutic agent.
Researchers tested the combination of arctigenin, green tea, and quercetin to enhance the anticancer effects on prostate cancer. They found a strong synergistic effect in vitro and significant inhibition of tumorigenesis in vivo. Clinical trials are needed to confirm efficacy in humans.
This study evaluated the antibacterial and antiproliferative activity of essential oils from four Zingiberaceae species for oral care. Curcuma xanthorrhiza and Curcuma mangga oils showed strong antibacterial properties, suggesting they could be used as natural alternatives in oral care products. Further research is needed to explore their therapeutic potential.
Researchers investigated the potential benefits of essential oils extracted from discarded citrus peels in preventing diseases caused by pathogens and oxidative stress. This utilization of agricultural waste promotes a sustainable agricultural economy and environmental protection.
Scientists developed a biosensor using gold nanoparticles and a lectin to detect abnormal sialic acid in cervical cancer cells. This method can differentiate between cancerous and non-cancerous cells, aiding in the early detection of cervical cancer.
Triptolide, an active compound from Tripterygium wilfordii, kills gastric cancer cells by increasing reactive oxygen species (ROS) levels. It targets peroxiredoxins-2 (PRDX2) to inhibit its antioxidant activity, leading to apoptosis. PRDX2 could be a potential therapeutic target for anti-gastric cancer agents.